Rate of Pharmacotherapy for Tobacco Smoking Cessation in Patients With New Peripheral Artery Disease

This cross-sectional study uses US insurance claims data to examine the rate of varenicline use for tobacco smoking cessation among adults with newly diagnosed peripheral artery disease.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2026-02-23
DOI
https://doi.org/10.1001/jamanetworkopen.2025.58244
Citations
1
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
39.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rate of Pharmacotherapy for Tobacco Smoking Cessation in Patients With New Peripheral Artery Disease

Kierstin Catlett, K. Roger Cohen, J. Murillo, Megan S. Jarvis et al.
1 citations
JAMA Network Open
Peripheral Artery Disease Management
39.15
article

Rate of Pharmacotherapy for Tobacco Smoking Cessation in Patients With New Peripheral Artery Disease

Kierstin Catlett, K. Roger Cohen, J. Murillo, Megan S. Jarvis, Binh T. Nguyen, Jane Sullivan, Omid Ameli
article en
1 citations

Abstract

This cross-sectional study uses US insurance claims data to examine the rate of varenicline use for tobacco smoking cessation among adults with newly diagnosed peripheral artery disease.

JAMA Network OpenVol. 9(2)
Optum (United States) (US), UnitedHealth Group (United States) (US)
Good health and well-being
Openalex Percentile: Top 1%
Peripheral Artery Disease Management
39.15
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.